CAS No. :	63074-08-8
Formula :	C₁₉H₂₆ClN₅O₄
M.W :	423.89
SMILES Code :	O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OCCC4.[H]Cl
Synonyms :	Terazosin (hydrochloride); Hytrin; A-45975
MDL No. :	MFCD00467965
InChI Key :	IWSWDOUXSCRCKW-UHFFFAOYSA-N
Pubchem ID :	44383

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302
Precautionary Statements:	P280-P305+P351+P338

HeLa cells	1/2 MIC (2 mg/mL)	1 hour	Evaluate the effect of Terazosin on S. Typhimurium invasion into HeLa cells. Terazosin significantly reduced bacterial invasion.	Antibiotics (Basel). 2022 Mar 30;11(4):465
RAW264.7 macrophages	1/2 MIC (2 mg/mL)	16 hours	Evaluate the effect of Terazosin on S. Typhimurium intracellular replication in macrophages. Terazosin significantly reduced bacterial intracellular replication.	Antibiotics (Basel). 2022 Mar 30;11(4):465
RAW 264.7 cells	10 µM	18-24 hours	TZ exhibited a protective effect against H2O2-induced apoptosis, as demonstrated by LDH release assay, active caspase-3 Western blot, and caspase activity assay.	Nat Chem Biol. 2015 Jan;11(1):19-25
RAW 264.7 cells	10 µM	18-24 hours	TZ suppressed apoptosis induced by LPS and IFN-γ, as verified by Annexin V staining and LDH release assay.	Nat Chem Biol. 2015 Jan;11(1):19-25
Mouse embryonic stem cell-derived motor neurons (mESC-MNs)	0.625, 1.25, 2.5 µM	24 hours	To evaluate the protective effect of Terazosin against oxidative stress-induced cell death, results showed Terazosin completely protected cells from death at the highest concentration	EBioMedicine. 2022 Sep;83:104202
Human neuroblastoma cells	10 µM	24 hours	Increased ATP content and reduced α-synuclein accumulation	J Clin Invest. 2019 Oct 1;129(10):4539-4549
MIN6 cells	20 µM	24 hours	Terazosin selectively activated GPR119, leading to increased cAMP and ATP synthesis, consequently enhancing insulin secretion.	Cell Prolif. 2025 Mar;58(3):e13764
Caco-2 cells	10 and 100 nM	24 hours	To evaluate the effect of Terazosin on cell viability under H2O2 and 2-DG-induced stresses, results showed that Terazosin significantly improved cell survival.	Int J Mol Sci. 2021 Dec 30;23(1):416
Chromobacterium violaceum CV026	1/2 MIC (2 mg/mL)	24 hours	Evaluate the effect of Terazosin on QS-controlled pigment production. Terazosin significantly reduced pigment release.	Antibiotics (Basel). 2022 Mar 30;11(4):465
Hepatic microsomes	0.5, 1, 2, 5, 20, 50, 100 µM	30 minutes	To determine the kinetic parameters (Vmax, Km, CLint) for the disappearance of terazosin in hepatic microsomes and evaluate the inhibitory effect of DA-8159 on its metabolism. Results showed that DA-8159 significantly reduced the metabolic rate of terazosin (Vmax decreased by 13.8%, CLint decreased by 62.0%).	Br J Pharmacol. 2007 May;151(1):24-34

Mice	VTA 6-OHDA dopamine depletion model	Oral administration via drinking water	0.03 mg/kg/day	Daily administration for approximately 16 days	To test the protective effect of Terazosin on PD-related cognitive dysfunction, results showed that Terazosin reduced interval timing variability in VTA dopamine-depleted mice	NPJ Parkinsons Dis. 2023 Mar 2;9(1):32
Mice	NAFPD model	Intraperitoneal injection	1.5 mg/kg	Daily for 6 weeks	Terazosin treatment improved hyperglycemia, obesity, and pancreatic β-cell dysfunction in NAFPD mice.	Cell Prolif. 2025 Mar;58(3):e13764
Female albino mice	S. Typhimurium infection model	Intraperitoneal injection	1/2 MIC (2 mg/mL)	Single injection, observed for 5 days	Evaluate the effect of Terazosin on S. Typhimurium pathogenesis. Terazosin significantly protected mice from S.Typhimurium pathogenesis.	Antibiotics (Basel). 2022 Mar 30;11(4):465
Mice	MPTP-induced PD model	Intraperitoneal injection	10 μg/kg	Once daily for 7 days	Increased brain ATP levels, slowed or prevented neuron loss, partially restored dopamine levels and motor function	J Clin Invest. 2019 Oct 1;129(10):4539-4549
Drosophila	HS>rpr Drosophila model	Oral	10 μM	24 hours	TZ significantly improved the survival rate of HS>rpr flies, indicating its inhibitory effect on apoptosis.	Nat Chem Biol. 2015 Jan;11(1):19-25
Zebrafish	C9orf72 knockdown and TDP-43G348C overexpression models	Added to water	2.5, 10, 50 µM	From 6 hpf until analysis at 30 hpf	To assess the ameliorative effect of Terazosin on motor neuron phenotypes, results showed Terazosin dose-dependently increased axon lengths	EBioMedicine. 2022 Sep;83:104202
C57BL/6N mice	DSS-induced ulcerative colitis and ethanol-induced gastric ulcer models	Intraperitoneal injection (ulcerative colitis) and oral administration (gastric ulcer)	4 mg/kg/day (ulcerative colitis) and 1 mg/kg/day (gastric ulcer)	Once daily for 7 days	To evaluate the protective effects of Terazosin on ulcerative colitis and gastric ulcer, results showed that Terazosin significantly alleviated clinical symptoms and inflammatory responses.	Int J Mol Sci. 2021 Dec 30;23(1):416
Sprague-Dawley rats	Healthy male rats	Intravenous and oral	5 mg/kg (i.v.); 5 mg/kg (p.o.)	Single dose	To evaluate the effect of DA-8159 on the pharmacokinetics and pharmacodynamics (blood pressure changes) of terazosin. Results showed that co-administration of DA-8159 and terazosin significantly increased the plasma concentration of terazosin (AUC increased by 57.4%-75.4%) and enhanced its blood pressure-lowering effect.	Br J Pharmacol. 2007 May;151(1):24-34
SD rats and spontaneously hypertensive rats (SHRs)	SD rats and SHRs	Transdermal iontophoresis	7.5 mg/1.5 g TEH hydrogel	10 hours	To evaluate the pharmacokinetic characteristics and antihypertensive effects of IDDS-TEH. Results showed that the blood concentration of IDDS-TEH was significantly higher than passive diffusion (p<0.05) and significantly reduced blood pressure in SHRs.	Drug Deliv. 2021 Dec;28(1):454-462

NCT00000620	Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less <<	Phase 3	Completed	-	United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less <<
NCT03339258	Stress Disorders, Post-Traumat... More >>ic Less <<	Phase 2	Recruiting	June 2021	United States, California ... More >> San Francisco VA Medical Center Recruiting San Francisco, California, United States, 94121 Contact: Andrew Levihn-Coon, B.A. 415-221-4810 ext 23809 andrew.levihn-coon@va.gov Less <<
NCT01323998	-		Completed	-	-
NCT00000620	-		Completed	-	-
NCT00684489	Hypertension	Not Applicable	Completed	-	-
NCT01323998	-		Completed	-	-
NCT01332487	-		Completed	-	-
NCT01332487	-		Completed	-	-
NCT03653845	Primary Aldosteronism ... More >> Hypertension Less <<	Phase 3	Recruiting	January 1, 2020	China, Chongqing ... More >> The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Hongbo He, MD. 86-23-68757880 cqhehongbo@gmail.com Principal Investigator: Zhiming Zhu, MD. China The third hospital affiliated to the Third Military Medical University Recruiting Chongqing, China, 400042 Contact: Zhiming Zhu, MD, PhD 86-023-68705094 zhuzm@yahoo.com Principal Investigator: Zhiming Zhu, MD, PhD Less <<
NCT01386983	-		Completed	-	-
NCT01332435	-		Completed	-	-
NCT01218243	Benign Prostatic Hyperplasia (... More >>BPH) Less <<	Phase 2	Completed	-	China ... More >> Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences Beijing, China, 100053 Less <<
NCT01390870	-		Completed	-	-
NCT01332435	-		Completed	-	-
NCT02966717	Renal Insufficiency, Chronic ... More >> Nephrotic Syndrome Less <<	Phase 2	Active, not recruiting	October 2021	China, Guangdong ... More >> Zhujiang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510282 Less <<
NCT01390870	-		Completed	-	-
NCT01218243	-		Completed	-	-
NCT01386983	-		Completed	-	-
NCT01435954	-		Completed	-	-
NCT00438113	Atrial Fibrillation	Phase 4	Completed	-	Canada, Nova Scotia ... More >> QE II Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 3A7 Less <<
NCT02244333	-		Completed	-	-
NCT00700583	Nocturia	Not Applicable	Completed	-	Korea, Republic of ... More >> Department of Urology, Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02046395	Type 2 Diabetes ... More >> Hypertension Less <<	Phase 4	Recruiting	December 2019	United States, Louisiana ... More >> Tulane University Health Sciences Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Bonnie L Katalenich, MPH 504-988-0200 bkatalen@tulane.edu Principal Investigator: Tina Thethi, MD, MPH Less <<
NCT01508637	Cardiovascular Effects	Not Applicable	Unknown	December 2015	United States, Washington ... More >> University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Less <<
NCT00687388	Benign Prostatic Hyperplasia	Phase 4	Withdrawn(in order to prepare ... More >>a new clinical trial to evaluate with pathological change) Less <<	-	Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00693199	Lower Urinary Tract Symptoms ... More >> Hypertension Less <<	Not Applicable	Completed	-	China, Anhui ... More >> Biomedicine Inistitute of Anhui Medical University Hefei, Anhui, China, 230032 Less <<
NCT01530243	Disorder of Urinary Stent	Phase 2 Phase 3	Completed	-	Iran, Islamic Republic of ... More >> Imam Khomeini Hospital Urmia, Azerbaijan-gharbi, Iran, Islamic Republic of Less <<
NCT00563485	Prostatic Hyperplasia ... More >> Urinary Retention Less <<	Not Applicable	Terminated	-	China ... More >> Prince of Wales Hospital Hong Kong, China Less <<
NCT01366664	Ejaculation	Phase 1	Completed	-	United States, Alabama ... More >> Anniston, Alabama, United States United States, Arizona Tempe, Arizona, United States United States, California Costa Mesa, California, United States United States, Florida Miramar, Florida, United States United States, Tennessee Knoxville, Tennessee, United States United States, Texas Dallas, Texas, United States Less <<
NCT03195673	Carotid Artery Stenosis	Phase 2	Recruiting	December 15, 2019	China, Beijing ... More >> Beijing Anzhen Hospital Recruiting Beijing, Beijing, China, 100029 Contact: He Yin, MD The Luhe Teaching Hospital of the Capital Medical University Recruiting Beijing, Beijing, China, 101100 Contact: Xiaokun Geng, MD Less <<
NCT02244255	Prostatic Hyperplasia	Phase 4	Completed	-	-
NCT00237510	Antidepressant Induced Excessi... More >>ve Sweating Less <<	Not Applicable	Completed	-	United States, Pennsylvania ... More >> Thomas Jefferson University Department of Psychiatry and Human Behavior Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00449683	Hyperhidrosis	Phase 4	Completed	-	United States, Pennsylvania ... More >> Thomas Jefferson University, Department of Psychiatry Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01530243	-		Completed	-	-

{[proInfo.proName]}

CAS No.: 63074-08-8

{[proInfo.proName]}

CAS No.: 63074-08-8

Alternative Products

Product Details of Terazosin HCl

Safety of Terazosin HCl

Related Pathways of Terazosin HCl

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed